Background. To the best of our knowledge, there have been no published reports on the diagnostic performance of the Chlamydia Rapid Test (CRT) Device for male urine samples. We evaluated the performance of the CRT Device when compared with that of the BD ProbeTec ET PCR Assay in a population of asymptomatic men. Methods. The study enrolled 100 men between June and July 2015. From each consenting male, 20-30 mL of urine was collected. Sensitivity and specificity of the rapid test compared to PCR were calculated. All analysis was performed in STATA version 13. Results. All men had valid rapid and PCR test results. The test showed a low sensitivity against PCR (20%) (95% CI 3.7-6.2%); however, an excellent specificity was observed (100%) (one sided 97.5% CI: 96.0-100). Conclusions. This test was not found to be suitable as a screening tool for genital Chlamydia infections in men. Our findings emphasize the need for more sensitive POC tests to be developed since the current approach for the management of STIs in Africa is confounded by poor sensitivity and specificity resulting in many infected individuals not being treated.
Introduction
Urogenital infection caused by Chlamydia trachomatis, the most common bacterial sexually transmitted infection (STI) in the world [1] , is associated with nongonococcal urethritis and epididymitis in men [2] . The prevalence of C. trachomatis in men in the African region is 2.1% with a reported incidence of 20.9 per a population of 1000 [3] . Additionally, C. trachomatis infections have also been shown to increase the risk of Human Immunodeficiency Virus (HIV) acquisition [4] . The documented increase in the number of reported cases of C. trachomatis infections has resulted in concerns regarding the effectiveness of current screening programs in parts of the United States as well as other countries [2] . Although nucleic acid amplification tests (NAATs) are significantly more sensitive than enzyme immunoassay based tests, performed with noninvasively collected specimens (urine) and used in screening asymptomatic individuals who represent the bulk of prevalent infections, there are still limitations regarding these tests. The foremost deterrent to the acceptance of NAATs has been their perceived cost [5] . Rapid point of care (POC) tests can be a cost effective strategy for increasing the impact of STI screening interventions. Their greatest advantage is that they can yield results at the patient's first visit, not requiring patient follow-up [6] . Currently, the available rapid tests for the detection of C. trachomatis have reasonable specificities [7, 8] . Various types of rapid tests for detecting C. trachomatis have been developed. The Chlamydia Rapid Test Device (Abon Biopharm (Hangzhou) Co., Ltd.) is a rapid chromatographic immunoassay for the qualitative detection of C. trachomatis in male urine samples. At present, the only information available on the test is product literature found on the manufacturer's package insert. To the best of our knowledge, there have been no published reports on the diagnostic performance of this POC test. The objective of this study is therefore to evaluate the diagnostic performance 2 Journal of Sexually Transmitted Diseases 
Results and Discussion
The median age of the men was 31 (IQR 23-38) years. All men had valid rapid and PCR test results. There were no invalid rapid tests. Four men had taken antibiotics in the past two weeks. However, these antibiotics did not affect the functioning of the rapid test, since no discordant results were observed between the rapid test and PCR in men who were medicated. We observed a 10% (95% CI 5.4-17.8) prevalence of asymptomatic genital chlamydial infections in this small study population. Reports on the prevalence of asymptomatic chlamydial genital tract infections in men have been estimated to range from 3% to approximately 50% [2, 9] . Currently, in South Africa there is limited data on asymptomatic Chlamydia infections in men. Despite our small sample size, the findings of our study therefore add to the growing body of knowledge on STI prevalence rates in a male population.
In our study, all 90 individuals who were negative on PCR also tested negative on the rapid test, resulting in a specificity of 100% (one sided 97.5% CI: 96.0-100). Eight out of the 10 PCR positives were incorrectly diagnosed as negative on the rapid test, resulting in a sensitivity of 20% (95% CI 3.7-6.2%) ( Table 1 ). The PPV and NPV were 100% and 91.8%, respectively. To date, available rapid tests for the detection of C. trachomatis have shown reasonable specificities but Journal of Sexually Transmitted Diseases 3 poor sensitivities when compared to other methods [8] . The findings of our study are consistent with a previous published report conducted in a clinical setting with specimens from asymptomatic men [10] . Of the men that tested positive, 60% had returned for their treatment visit which was scheduled within 7 days of their initial clinic visit.
One of the reasons for the observed poor sensitivity could be inadequate microbial load since some of the rapid tests require a high organism load [11] . A distinct relationship between organism load and rapid test performance has been reported by Nadala et al. [12] and Hurly et al. [10] . However, this is not practical in a clinical setting since the microbial load varies for each patient [11] and the detection of the organism is affected by patient factors such as being asymptomatic [6] .
Conclusion
Whilst the sensitivity of the test was low, the specificity of the rapid test was excellent when compared to the reference test and this is in keeping with a previous finding that reported promising levels of specificity for Chlamydia Rapid Tests for detecting infections in asymptomatic men [10] . Our findings emphasize the need for more sensitive POC tests to be developed since the current approach for the management of STIs in Africa is confounded by poor sensitivity (30-80%) and specificity (40-80%), resulting in many infected individuals not being treated [13] .
